Evidence map›Paper›PMID 33196429›Full record

ArticleThe Permanente journal2020

A Pharmacist-Led Program to Taper Opioid Use at Kaiser Permanente Northwest: Rationale, Design, and Evaluation.

Jennifer L Kuntz, Jennifer L Schneider, Alison J Firemark, John F Dickerson, Dea Papajorgji-Taylor, Katherine R Reese, Traci A Hamer, Darlene Marsh, Lou Ann Thorsness, Mark D Sullivan and 2 more

Abstract read
In one paragraph

Article in The Permanente journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Factors associated with opioid-tapering success: A mixed methods study.Journal of the American Pharmacists Association : JAPhA
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jennifer L KuntzKaiser Permanente Northwest Center for Health Research, Portland, OR.
Jennifer L SchneiderKaiser Permanente Northwest Center for Health Research, Portland, OR.
Alison J FiremarkKaiser Permanente Northwest Center for Health Research, Portland, OR.
John F DickersonKaiser Permanente Northwest Center for Health Research, Portland, OR.
Dea Papajorgji-TaylorKaiser Permanente Northwest Center for Health Research, Portland, OR.
Katherine R ReeseKaiser Permanente Northwest Clinical Pharmacy Services, Portland, OR.
Traci A HamerKaiser Permanente Northwest Clinical Pharmacy Services, Portland, OR.
Darlene MarshKaiser Permanente Northwest Clinical Pharmacy Services, Portland, OR.
Lou Ann ThorsnessKaiser Permanente Northwest Clinical Pharmacy Services, Portland, OR.
Mark D SullivanPsychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA.
Lynn L DebarKaiser Permanente Washington Health Research Institute, Seattle, WA.
David H SmithKaiser Permanente Northwest Center for Health Research, Portland, OR.

Funding

Facilitating Lower Opioid Amounts Through TaperingR01DA042124 · NIDA · KAISER FOUNDATION RESEARCH INSTITUTE · PI SMITH, DAVID H · 2017 to 2019
$1.3M
NIDA NIH HHS R01 DA042124
6 · The paper itself

Abstract

introductionPrimary care practitioners (PCPs) are concerned about adverse effects and poor outcomes of opioid use but may find opioid tapering difficult because of a lack of pain management training or time constraints limiting patient counseling. In 2010, Kaiser Permanente Northwest implemented a pharmacist-led opioid tapering program-Support Team Onsite Resource for Management of Pain (STORM)-to address high rates of opioid use, alleviate PCPs' workload demands, and improve patient outcomes.

objectiveTo describe the rationale, structure, and delivery of this unique pharmacist-led program, which partners with PCPs and provides individualized care to help patients reduce opioid use, and the Facilitating Lower Opioid Amounts through Tapering study, which examines the program's effectiveness, cost-effectiveness, and implementation.

resultsThe STORM program includes a pain medicine physician, a social worker or nurse, and pharmacists who have received specialized clinical and communications training. The program has a 2-fold role: 1) to provide PCP education about pain management and opioid use and 2) to offer clinician and patient support with opioid tapering and pain management. After program training, PCPs are equipped to discuss the need for tapering with a patient and to refer to the program. Program pharmacists provide a range of services, including opioid taper plans, nonopioid pain management recommendations, and taper-support outreach to patients. DISCUSSION: The STORM program provides individualized care to assist patients with opioid tapering while reducing the burden on PCPs.

conclusionThe STORM program may be a valuable addition to health care systems and settings seeking options to address their patients' opioid tapering needs.

Indexed as

Analgesics, OpioidOpioid-Related DisordersHumansPain ManagementPharmacistsPrimary Health CareAnalgesics, Opioid

Identifiers

PMID33196429
PMCPMC7213382

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.